Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI).
Saved in:
| Title: | Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI). |
|---|---|
| Authors: | Chae, Heejung1,2 (AUTHOR), Sim, Sung Hoon1,3 (AUTHOR), Kwon, Youngmi4 (AUTHOR), Lee, Eun-Gyeong5 (AUTHOR), Han, Jai Hong5 (AUTHOR), Jung, So-Youn5,6 (AUTHOR), Lee, Seeyoun5 (AUTHOR), Kang, Han-Sung5 (AUTHOR), Kim, Yeon-Joo7 (AUTHOR), Kim, Tae Hyun7 (AUTHOR), Lee, Keun Seok1 (AUTHOR) kslee@ncc.re.kr |
| Source: | Cancers. Sep2024, Vol. 16 Issue 18, p3122. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers16183122 |
